Estradiol dienantate
Estradiol dienantate, or estradiol 3,17-dihepanoate, is an estrogen and an estrogen ester.[1] It is the C3 and C17β dienanthate (diheptanoate) ester of estradiol.[1] The medication is a component of Climacteron, an injectable combination formulation of testosterone enantate benzilic acid hydrazone, estradiol dienantate, and estradiol benzoate which was previously used in the treatment of menopausal symptoms in women.[2][3][4]
![]() | |
Clinical data | |
---|---|
Other names | Estradiol dienanthate; Estradiol diheptanoate; Estra-1,3,5(10)-triene-3,17β-diol diheptanoate |
Routes of administration | Intramuscular injection |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.028.903 ![]() |
Chemical and physical data | |
Formula | C32H48O4 |
Molar mass | 496.721 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
References
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 898. ISBN 978-1-4757-2085-3.
- Ginsburg, Elizabeth S. (1999). "Androgen Replacement in Postmenopausal Women". In Seifer, David B.; Kennard, Elizabeth A. (eds.). Menopause. 18. pp. 209–219. doi:10.1007/978-1-59259-246-3_13. ISBN 978-1-61737-129-5.
- Robert B. Greenblatt; William E. Barfield; Edwin C. Jungck (January 1962). "The treatment of the menopause". Can Med Assoc J. 86 (3): 113–4. PMC 1848811. PMID 13901504.
- David B. Seifer (27 July 1999). Menopause: Endocrinology and Management. Springer Science & Business Media. pp. 183–. doi:10.1007/978-1-59259-246-3. ISBN 978-1-59259-246-3.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.